ACAD
ACADIA Pharmaceuticals Inc
22.20$
-12.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -35.6% | -27.0% | +97.8% | +27.4% | +54.9% | +43.3% | +50.3% | -51.9% | -23.2% | -22.7% | -16.4% | +238.1% | +74.2% | +72.1% | -31.8% | +152.9% | -31.5% | +40.5% | +45.0% | -0.1% | -10.5% | -16.0% | +27.4% | +58.6% | +31.7% | |
| – | – | – | +113.4% | +33.8% | +59.0% | +42.7% | +53.0% | -52.5% | -22.3% | -21.9% | -15.6% | +239.8% | +73.5% | +72.3% | -32.5% | +150.2% | -31.8% | +40.9% | +44.5% | -5.6% | -13.9% | -17.8% | +21.3% | +52.3% | +13.2% | |
| – | – | – | +41.6% | +31.6% | +18.0% | +58.0% | +9.7% | +24.6% | -14.4% | -62.2% | +0.6% | +740.5% | -79.8% | +428.4% | +65.1% | +60.2% | -57.6% | +94.1% | +40.8% | +71.9% | -54.8% | -22.1% | +64.3% | +69.4% | -44.4% | |
| – | – | – | +118.8% | +32.0% | +19.7% | +93.6% | +52.4% | -52.6% | -21.7% | -21.2% | -16.3% | +247.7% | +72.1% | +73.6% | -33.3% | +145.9% | -35.5% | +38.7% | +47.3% | -9.4% | -17.6% | -20.0% | +5.3% | +72.3% | +8.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +69.9% | +335.9% | +158.1% | +50.8% | +36.3% | +32.8% | +30.0% | -3.5% | +62.3% | +2.3% | +41.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +25.7% | -22.4% | +55.8% | +52.7% | -18.6% | -15.8% | +439.8% | -38.7% | +58.0% | |
| – | – | – | +28.9% | -18.3% | -10.4% | +53.5% | -13.0% | -31.0% | -49.5% | -59.9% | -64.6% | -72.2% | +1,278.6% | -4.5% | +298.4% | +39.9% | -13.6% | +24.3% | -3.9% | +188.1% | +623.9% | -7.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -21.1% | -26.7% | -36.4% | -57.1% | – | – | – | +82.9% | -9.1% | |
| – | -92.8% | +1,269.6% | +50.3% | -88.5% | +138.9% | -3.2% | -7.8% | -43.4% | +221.5% | -76.8% | +0.5% | +169.7% | -70.4% | +128.6% | +38.6% | +93.1% | +15.2% | +24.2% | +37.5% | +85.1% | +2.3% | +17.7% | +69.3% | +43.4% | -26.0% | |
| – | – | – | +33.7% | +5.0% | +151.2% | -5.4% | -6.1% | -42.7% | +33.1% | -59.5% | +3.5% | -3.5% | +17.3% | +126.9% | +38.3% | +94.4% | +15.1% | +21.5% | +25.6% | +41.6% | -9.3% | +30.8% | +102.4% | +55.3% | -29.8% | |
| – | – | – | +9.0% | -54.2% | -40.1% | +11.9% | -1.8% | -18.7% | -54.1% | -78.6% | -59.0% | – | – | – | – | – | – | – | – | +48.1% | +63.2% | +12.1% | +1.1% | +5.9% | +16.8% | |
| – | – | – | +36.8% | +40.5% | -3.7% | +63.4% | -23.5% | -11.9% | +29.1% | -33.1% | -0.6% | -29.8% | -72.9% | +441.9% | -17.1% | +134.0% | +124.6% | -64.0% | +128.0% | +17.6% | -19.0% | +85.4% | +37.6% | -7.7% | -32.7% | |
| – | – | – | -53.0% | -35.7% | -14.6% | +54.6% | -16.2% | -62.8% | -77.2% | -67.3% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -324.4% | – | – | +28.3% | +70.6% | +69.6% | -53.5% | -77.1% | +145.1% | -21.3% | +263.8% | +114.3% | +69.9% | -35.5% | +159.5% | -35.3% | +42.9% | +45.9% | -10.3% | -13.7% | -26.0% | +7.8% | +69.7% | +67.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +12.9% | +20.2% | +682.7% | -8.9% | +112.6% | +26.8% | +26.1% | +5.4% | +1.0% | +3.3% | +34.8% | +5.6% | +55.5% | +13.5% | +3.5% | +15.1% | +5.8% | +3.2% | +16.3% | +6.9% | +2.0% | +0.7% | +1.3% | +1.6% | +3.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.